Sawai Pharmaceutical Co Ltd (Sawai Pharmaceutical) manufactures, sells, imports, and exports ethical drugs and proprietary drugs. The company’s line of products includes around 800 ethical pharmaceuticals, such as cardiovascular drugs, antihyperlipidemic agents, diabetes drugs, anticancer drugs, and OTC drugs. The company’s products are manufactured in various formulations including tablet, oral dispersing tablet, capsule, granule, injection, tape, ophthalmic/nasal solution and syrup among others. It covers therapeutic areas including cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, chemotherapeutics, vitamins and anti-cancer, among others.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

The company’s R&D activities focus on bringing generic drugs to the market promptly after patent expiration or reexamination. The company continuously seeks ideas to add value and integrate these into products efficiently and cost-effectively, significantly reducing medical expenses in Japan. Technologies such as controlled release technology have been crucial in ensuring new products are first to market. The company adopts a cross-organizational approach to address consumer issues and enhance products, aiming to create pharmaceutical products with advantages like ease of administration and reliable availability.